Found: 51
Select item for more details and to access through your institution.
Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil.
- Published in:
- Radiation Oncology, 2012, v. 7, n. 1, p. 1, doi. 10.1186/1748-717X-7-185
- By:
- Publication type:
- Article
Detection of local recurrent prostate cancer after radical prostatectomy in terms of salvage radiotherapy using dynamic contrast enhanced-MRI without endorectal coil.
- Published in:
- 2012
- By:
- Publication type:
- journal article
FDG-PET/CT Imaging Predicts Histopathologic Treatment Responses after Neoadjuvant Therapy in Adult Primary Bone Sarcomas.
- Published in:
- Sarcoma, 2010, p. 1, doi. 10.1155/2010/143540
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT for Monitoring Treatment Responses to the Epidermal Growth Factor Receptor Inhibitor Erlotinib.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 11, p. 1684, doi. 10.2967/jnumed.111.095257
- By:
- Publication type:
- Article
Metabolic Imaging Allows Early Prediction of Response to Vandetanib.
- Published in:
- Journal of Nuclear Medicine, 2011, v. 52, n. 2, p. 231, doi. 10.2967/jnumed.110.081745
- By:
- Publication type:
- Article
Correlation Between Glycolytic Phenotype and Tumor Grade in Soft-Tissue Sarcomas by <sup>18</sup>F-FDG PET.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 8, p. 1174, doi. 10.2967/jnumed.109.074229
- By:
- Publication type:
- Article
Imaging of CTLA4 Blockade--Induced Cell Replication with <sup>18</sup>F-FLT PET in Patients with Advanced Melanoma Treated with Tremelimumab.
- Published in:
- Journal of Nuclear Medicine, 2010, v. 51, n. 3, p. 340, doi. 10.2967/jnumed.109.070946
- By:
- Publication type:
- Article
<sup>18</sup>F-FDOPA PET and PET/CT Accurately Localize Pheochromocytomas.
- Published in:
- Journal of Nuclear Medicine, 2009, v. 50, n. 4, p. 513, doi. 10.2967/jnumed.108.058396
- By:
- Publication type:
- Article
Combined Assessment of Metabolic and Volumetric Changes for Assessment of Tumor Response in Patients with Soft-Tissue Sarcomas.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 10, p. 1579, doi. 10.2967/jnumed.108.053694
- By:
- Publication type:
- Article
Treatment Monitoring by <sup>18</sup>F-FDG PET/CT in Patients with Sarcomas: Interobserver Variability of Quantitative Parameters in Treatment-Induced Changes in Histopathologically Responding and Nonresponding Tumors.
- Published in:
- Journal of Nuclear Medicine, 2008, v. 49, n. 7, p. 1038, doi. 10.2967/jnumed.107.050187
- By:
- Publication type:
- Article
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.267234
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266732
- By:
- Publication type:
- Article
PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266722
- By:
- Publication type:
- Article
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 8, p. 1, doi. 10.2967/jnumed.123.266391
- By:
- Publication type:
- Article
RECIP 1.0 Predicts Progression-Free Survival After [<sup>177</sup>Lu]Lu-PSMA Radiopharmaceutical Therapy in Patients with Metastatic Castration-Resistant Prostate Cancer.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 6, p. 917, doi. 10.2967/jnumed.123.267234
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 820, doi. 10.2967/jnumed.123.266732
- By:
- Publication type:
- Article
PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 5, p. 818, doi. 10.2967/jnumed.123.266722
- By:
- Publication type:
- Article
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 3, p. 438, doi. 10.2967/jnumed.123.266391
- By:
- Publication type:
- Article
PSMA PET/CT Dual-Time-Point Imaging: Nice to Have or Need to Have?
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266722
- By:
- Publication type:
- Article
[<sup>68</sup>Ga]Ga-FAPI-46 PET in a Borderline Ovarian Tumor.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266732
- By:
- Publication type:
- Article
Differences and Common Ground in <sup>177</sup>Lu-PSMA Radioligand Therapy Practice Patterns: International Survey of 95 Theranostic Centers.
- Published in:
- Journal of Nuclear Medicine, 2024, v. 65, n. 2, p. 1, doi. 10.2967/jnumed.123.266391
- By:
- Publication type:
- Article
PSMA PET Tumor-to-Salivary Gland Ratio to Predict Response to [<sup>177</sup>Lu]PSMA Radioligand Therapy: An International Multicenter Retrospective Study.
- Published in:
- Journal of Nuclear Medicine, 2023, v. 64, n. 7, p. 1024, doi. 10.2967/jnumed.122.265242
- By:
- Publication type:
- Article
Novel Framework for Treatment Response Evaluation Using PSMA PET/CT in Patients with Metastatic Castration-Resistant Prostate Cancer (RECIP 1.0): An International Multicenter Study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 11, p. 1651, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 10, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with 2 metastatic castration-resistant prostate cancer (RECIP 1.0): 3 an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 9, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 6, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
Novel framework for treatment response evaluation using PSMA-PET/CT in patients with metastatic castration-resistant prostate cancer (RECIP 1.0): an international multicenter study.
- Published in:
- Journal of Nuclear Medicine, 2022, v. 63, n. 5, p. 1, doi. 10.2967/jnumed.121.263072
- By:
- Publication type:
- Article
<sup>18</sup>F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262502
- By:
- Publication type:
- Article
Correlation of 68Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: a prospective translational exploratory study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.262426
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261952
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 12, p. 1, doi. 10.2967/jnumed.121.261952
- By:
- Publication type:
- Article
<sup>18</sup>F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262502
- By:
- Publication type:
- Article
Correlation of <sup>68</sup>Ga-FAPi-46 PET biodistribution with FAP expression by immunohistochemistry in patients with solid cancers: a prospective translational exploratory study.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.262426
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 11, p. 1, doi. 10.2967/jnumed.121.261952
- By:
- Publication type:
- Article
<sup>18</sup>F-FLT PET/CT as a prognostic imaging biomarker of disease specific survival in patients with primary soft tissue sarcoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.262502
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 10, p. 1, doi. 10.2967/jnumed.121.261952
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 8, p. 1, doi. 10.2967/jnumed.121.261952
- By:
- Publication type:
- Article
<sup>18</sup>F-FDG PET/CT imaging biomarkers for early and late evaluation of response to first-line chemotherapy in patients with pancreatic ductal adenocarcinoma.
- Published in:
- Journal of Nuclear Medicine, 2021, v. 62, n. 7, p. 1, doi. 10.2967/jnumed.121.261952
- By:
- Publication type:
- Article
Correlation of the Genotype of Paragangliomas and Pheochromocytomas with Their Metabolic Phenotype on 3,4-Dihydroxy-6-<sup>18</sup>F-Fluoro-L-Phenylalanin PET.
- Published in:
- Journal of Nuclear Medicine, 2012, v. 53, n. 9, p. 1352, doi. 10.2967/jnumed.111.101303
- By:
- Publication type:
- Article
Metal implants on abdominal CT: does split-filter dual-energy CT provide additional value over iterative metal artifact reduction?
- Published in:
- Abdominal Radiology, 2023, v. 48, n. 1, p. 424, doi. 10.1007/s00261-022-03682-3
- By:
- Publication type:
- Article
Dual-energy CT of acute bowel ischemia.
- Published in:
- Abdominal Radiology, 2022, v. 47, n. 5, p. 1660, doi. 10.1007/s00261-021-03188-4
- By:
- Publication type:
- Article
Quantitative enhancement thresholds and machine learning algorithms for the evaluation of renal lesions using single-phase split-filter dual-energy CT.
- Published in:
- Abdominal Radiology, 2020, v. 45, n. 6, p. 1922, doi. 10.1007/s00261-019-02195-w
- By:
- Publication type:
- Article
Fibroblast Activation Protein Expression in Sarcomas.
- Published in:
- Sarcoma, 2023, p. 1, doi. 10.1155/2023/2480493
- By:
- Publication type:
- Article
(18) F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
- Published in:
- 2013
- By:
- Publication type:
- Journal Article
<sup>18</sup>F-Fluorodeoxyglucose positron emission tomography/computed tomography for the detection of recurrent bone and soft tissue sarcoma.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 6, p. 1227, doi. 10.1002/cncr.27866
- By:
- Publication type:
- Article
3'-deoxy-3'-[18F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma: a pilot study to correlate imaging findings with tissue thymidine kinase 1 and Ki-67 activity and histopathologic response.
- Published in:
- 2012
- By:
- Publication type:
- journal article
3′-deoxy-3′-[<sup>18</sup>F]fluorothymidine positron emission tomography for response assessment in soft tissue sarcoma.
- Published in:
- Cancer (0008543X), 2012, v. 118, n. 12, p. 3135, doi. 10.1002/cncr.26630
- By:
- Publication type:
- Article
Measuring response in metastatic castration-resistant prostate cancer using PSMA PET/CT: comparison of RECIST 1.1, aPCWG3, aPERCIST, PPP, and RECIP 1.0 criteria.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 12, p. 4271, doi. 10.1007/s00259-022-05882-x
- By:
- Publication type:
- Article
High <sup>68</sup> Ga-FAPI-46 uptake in a pulmonary necrotizing granuloma in a patient with subcutaneous lipoma.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2022, v. 49, n. 3, p. 1088, doi. 10.1007/s00259-021-05510-0
- By:
- Publication type:
- Article
<sup>68</sup>Ga-FAPI-46 and <sup>18</sup>F-FDG PET/CT in a patient with immune-related thyroiditis induced by immune checkpoint inhibitors.
- Published in:
- European Journal of Nuclear Medicine & Molecular Imaging, 2021, v. 48, n. 11, p. 3736, doi. 10.1007/s00259-021-05373-5
- By:
- Publication type:
- Article